Active-ingredient Dossier

Entacapone

Active-ingredient Dossier for Entacapone (catechol-o-methyltransferase inhibitor). Australian brands, products, PBS listings, PBAC outcomes — compiled by…

Brand: COMTAN
Brand: LECTEVA
Brand: CARLEVENT
Brand: LECIGON
Brand: STALEVO
Therapeutic area: Neurology

What is

Entacapone Entacapone is a catechol-o-methyltransferase inhibitor.

Australian brands containing

Entacapone — COMTAN — LECIGON — CARLEVENT — STALEVO

Therapeutic areas

Entacapone is registered in neurology, with 4 brands marketed in this therapeutic area.

Sponsor landscape

Three sponsors market entacapone in Australia: Sandoz, Arrotex Pharmaceuticals, and Stada Pharmaceuticals.

PBS and regulatory activity

One brand containing entacapone is PBS-listed, with the latest PBS schedule date being 1 May 2026. The latest PBAC outcome on record is 1 November 2024.